民族医药领域首部疾病分类国家标准发布

Core Viewpoint - The approval and release of the "Tibetan Medicine Disease Classification and Codes" (GB/T 46946—2025) by the State Administration for Market Regulation marks a significant step in the standardization of Tibetan medicine, set to be implemented from April 1 [1][2]. Group 1: Standard Overview - The standard is the first national disease classification standard in the field of ethnic medicine in China, indicating a crucial advancement in the standardization of Tibetan medicine [2]. - It categorizes Tibetan diseases into three major genetic diseases and 15 categories, along with 97 subcategories, providing a comprehensive coding system for over 3,000 diseases [1][2]. Group 2: Implications of the Standard - The standard unifies the disease naming system, addressing issues of "multiple names for one disease" and "different names for the same disease," thus providing a consistent basis for clinical diagnosis, academic exchange, and medical management [2]. - It highlights the clinical characteristics of Tibetan medicine, systematically organizing and showcasing its advantageous diseases, which aids in leveraging Tibetan medicine's unique role in the prevention and treatment of specific diseases [2]. - The standard supports medical quality control by providing scientific monitoring indicators for the evaluation and management of Tibetan medical services, contributing to the continuous improvement of service quality [2]. - It promotes the construction of a data platform, laying the groundwork for a big data platform for Tibetan medicine, and offers reliable data support for medical insurance settlement and health statistics [2].